LENZ Therapeutics, Inc.

The momentum for this stock is not very good. LENZ Therapeutics, Inc. is not a good value stock. LENZ Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in LENZ Therapeutics, Inc..

News

Lenz Therapeutics files to sell 1.58M shares of common stock for holders

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Contrasting LENZ Therapeutics (NASDAQ:LENZ) and SOPHiA GENETICS (NASDAQ:SOPH)

Ticker Report SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) and LENZ Therapeutics (NASDAQ:LENZ - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two...\n more…

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives $35.00 Average Price Target from Analysts

Zolmax LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has received an average recommendation of "Buy" from the six ratings firms that are presently covering the company, Marketbeat.com reports...\n more…

Analysts Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) PT at $35.00

Ticker Report LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six analysts that are presently covering the firm, Marketbeat reports. Five...\n more…

Reviewing LENZ Therapeutics (NASDAQ:LENZ) & SOPHiA GENETICS (NASDAQ:SOPH)

Zolmax SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) and LENZ Therapeutics (NASDAQ:LENZ - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...\n more…

LENZ Stock Earnings: LENZ Therapeutics Misses EPS for Q1 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nLENZ stock results show that LENZ Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.\nThe post LENZ...\n more…